Last week, nearly 200 customers joined us in our hometown of Madison, WI for the 28th Onsemble Conference. Attendees spent the week networking with colleagues, learning from research operations experts, enjoying Madison and collaborating to move clinical research forward.
For those going into the conference wondering how Forte’s recent acquisition by Advarra would affect the community, attendees quickly found it was business as usual. From the early-week workshops to the final night dinner, the conference reminded us how Onsemble reflects the values of both Forte and our incredible customer community. Focusing on collaboration, education, networking (and a bit of fun), the conference was one to remember.
Focusing on What’s Ahead
One of the many perks of attending the conference is getting a sneak peek at what’s coming soon from Forte. Important products and initiatives like the Trial Data Exchange (TDX), Forte Insights and Forte Benchmarks were all unveiled at Onsemble Conferences. This fall, attendees learned about our vision for the future of Forte and Advarra, and received an update on TDX. They also heard about Forte’s new Agile development methodology, which will result in a more streamlined, consistent release process.
During the TDX update, Forte’s Chief Product Officer James Wurdeman highlighted progress with OnCore Enterprise Research System, Forte eReg and Forte EDC. TDX aims to create a two-sided network of systems used to collect operational, regulatory and clinical/source data, connecting sites and sponsors for more efficient and higher quality clinical trials. He showed how Forte is building a foundation of standardization and interconnectivity between products, making it possible for TDX to become a reality.
Wurdeman also outlined new Vendor Payables functionality in OnCore. A popular topic among customers, the new functionality was released last month in OnCore 16.0. Vendor Payables adds to OnCore’s comprehensive financial management, allowing organizations to track payable charges at both the protocol and subject level. A true example of the power of the Onsemble Community, our team collaborated with nearly 100 representatives from 31 unique institutions to ensure this new functionality meets the needs of academic medical centers, cancer centers and health systems.
Later, Wurdeman provided an overview of new task list dashboards within our Forte Insights business intelligence solution. The new dashboards use OnCore task lists to populate study activation data, providing a glimpse into how long each piece the activation process is taking. The dashboards easily allow customers to analyze the activation process as a whole, while also providing the ability to drill down into areas of concern to identify which specific tasks are creating bottlenecks. Because the dashboards are configured to the organization’s task lists within OnCore, the new dashboards provide flexibility for customers to analyze milestones most critical to them.
Forte Customers Share Their Experiences
Another popular aspect of the product update is our customer highlight, where experienced users of Forte technology share their successes and lessons learned with the audience. First, Sarah Stewart, Assistant Director of Clinical Research at the University of Wisconsin Carbone Cancer Center outlined her experience with Forte Insights. Like many customers at NCI-designated cancer centers, Stewart needs to maintain a significant amount of data on accruals, participant demographics and more, which she previously accomplished through OnCore reports and Excel documents.
Stewart said she uses the system daily to analyze her team’s progress for an upcoming External Advisory Board review, identify problem protocols using Insights’ PI dashboards and quickly answer ad-hoc questions from throughout the cancer center. “Insights has changed my life,” she said. “And as always, it’s been great working with Forte to develop and improve these dashboards. In addition to seeing my suggestions get implemented within Insights, it’s been great to benefit from the contributions of the entire community.”
Attendees then heard from Kirsten Linsenmeyer, OnCore Administrator and Team Lead at The Ohio State University James Comprehensive Cancer Center, who shared her experience with the Forte eRegulatory Management System. As the first customer to go live with Forte eReg, Kirsten and her team were instrumental in optimizing Forte’s processes for system implementation, data migration and 21 CFR Part 11 validation. Linsenmeyer outlined her journey throughout the process, and shared some impressive numbers since OSU went live with the system: In just a few months, they already have more than 10,000 electronic signatures and have stored more than 40,000 documents within the eReg system. She also highlighted improved monitoring processes as a result in the system, and said her regulatory team has received extremely positive feedback from both staff and sponsors.
If you’d like to learn more about Forte technology we highlighted at the conference, sign up to attend an open demo:
October 1, 2019 at 11 a.m. CST
Register for Insights Demo
October 8, 2019 at 11 a.m. CST
Register for eReg Demo
October 15, 2019 at 11 a.m. CST
Register for EDC Demo
Nov 6, 2019 at 2 p.m. CST
Register for EVAL Demo